Genmab (GMAB) Q3 2026 Earnings Call Transcript
Strong royalties and pipeline progress, but litigation risks remain in focus.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
California takes CoinFlip to task
The state ordered the crypto ATM company to pay $4.8 million to scam victims, and bashed federal regulators over failing to police for fraud.
Sarepta (SRPT) Q3 2026 Earnings Call Transcript
Gene therapy demand stabilizes while siRNA readouts and FDA talks loom ahead.
AVITA Medical (RCEL) Q3 2026 Earnings Call Transcript
Going concern warning removed as revenue jumps and guidance rises again.
Acorn Energy (ACFN) Q3 2026 Earnings Call Transcript
The first acquisition adds recurring revenue as cash stays strong.
Should Realty Income Be the First Dividend Stock You Buy in November, Even if There's a Stock Market Sell-Off?
Steady and reliably growing dividends are just the start of this REIT's appeal.
- Realty Income offers monthly payouts ideal for fixed-income reliance.
- The company has increased payouts for 31 straight years and 116 consecutive quarters.
- Realty Income's tenants sign triple-net leases, providing stability amid economic downturns.
5 Stocks Down More Than 50% From Their Record Highs to Buy Now
Five consumer goods stocks have lost more than half their value from their peaks, but the market might be looking at the wrong things.
- Hormel Foods (HRL) down 60% from 2020 high, acquiring Brakebush Brothers
- Helen of Troy (HELE) fell 89% from 2021 peak, benefiting from tariff refunds
- Energizer Holdings (ENR) down 50% from 2018 high, growing auto care sales